Approximately $350 million in preventable losses stem from polymorphic malware, malicious software that constantly changes its code to evade detection. With 18% of new malware using adaptive ...
SGT-212 has been granted FDA Rare Pediatric Disease and Fast Track designations – – SGT-212 is the only dual route gene therapy in development to treat Friedreich’s ataxia – CHARLESTOWN, Mass., Dec.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback